Pregnancy and living with HIV

Slides:



Advertisements
Similar presentations
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Advertisements

Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
Early Infant Diagnosis: Challenges and Solutions A special session IAS, Vienna 2010.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Dr. Laura Guay Vice President for Research Elizabeth Glaser Pediatric AIDS Foundation J2J Global Media Training on HIV/AIDS July 14, 2010 Vienna, Austria.
Virologic and immunologic response following antiretroviral therapy initiation among pregnant and postpartum women with acute HIV-1 infection: MOPDB0101.
Primary Healthcare Facilities Deliver More Effective Antiretroviral Therapy: An Evaluation in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
Feedback from Pregnancy research group UK CHIC / UK HIV Drug Resistance Database Meeting, 2 July 2010 Pregnancy Group: Jane Anderson, Loveleen Bansi, Susie.
Purpose Provide concepts and latest research findings related to prevention of mother-to-child transmission of HIV (PMTCT) for application in the workplace.
Presenter : Dr T. G. Nematadzira on behalf of The IMPAACT PROMISE 1077BF/1077FF Team Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission.
ART Regimen Selection and Treatment Initiation for PMTCT Programs Lara Stabinski, MD, MPH Medical Officer Clinical Services S/GAC June 18, 2012.
Presented by: Jennifer Bryce Institute for International Programs Johns Hopkins Bloomberg School of Public Health Mortality and Coverage: Where are we.
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPACT) Group PROMISE (BREAST FEEDING) 1077 AAHU STC 2013 Group 2 Cedric Sturdevant,
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
____________________________________ Commonwealth Foundation Partner’s Forum 9 th Commonwealth Women’s Affairs Ministers’ Meeting Gender issues in the.
Reproductive Health Needs of Men and Women Enrolled in HIV Care and Treatment Services Elaine Abrams August 12, 2008 Track 1.0 Meeting.
Child Health: How Have We Been Doing; Where to Now? An Update on MDG 4 and 5: Maternal and Child Health By Dr. Mickey Chopra, Chief, Health and Associate.
 Child death rates are decreasing, but not quickly enough  Many developed countries have managed to decrease their under-five mortality rates  These.
SEVERE ACUTE MATERNAL MORBIDITY/NEAR MISS MATERNAL MORBIDITY Sangeetagupta Seniorconsultant&HOD, Deptt of Obst.&Gynae,ESIPGIMSR,Basaidarapur.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Is Highly Active Antiretroviral Therapy (HAART) in pregnancy protective against maternal mortality? Results from a large DREAM cohort in Malawi and Mozambique.
Provider initiated testing in Kenya Ruth Nduati Associate Prof Paediatrics University of Nairobi.
HIV DISEASE IN PREGNANCY
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Exposure and response to highly active antiretroviral therapy (HAART) in ART naïve children in the UK and Ireland Judd A. 1, Lee K.J. 1, Duong T. 1, Walker.
A Call to Action Children – The missing face of AIDS.
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection The INSIGHT START Study Group Ben Andres Oct 15, 2015.
STATE OF THE EPIDEMIC AND THE RESPONSE PROMISES, PROGRESS AND PROBLEMS DR. ALEX COUTINHO MD MPH Executive Director Infectious Diseases Institute.
BARRIERS TO AND FACILITATORS FOR RETENTION OF MOTHER BABY-PAIRS IN CARE IN ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV IN EASTERN UGANDA Gerald.
PMTCT 365 Days of Action to end the hidden violence against women and children Protecting Women early.
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Trends in maternal deaths in HIV-infected women, on a background of changing HIV management guidelines in South Africa: 1997 to ,2,3CN Mnyani, 1EJ.
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
Contribution of ALPHA results to global estimates and policy
Earlier treatment and lower mortality in infants Initiating ART at
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Vital statistics in obstetrics.
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
XVI I IAC Mexico 3-8 August 2008 Txema Calleja WHO/OMS
Tabassum Firoz MD MSc FRCPC University of British Columbia
Maternal & Perinatal Mortality
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
HIV-associated TB mortality and blocks in the cascade
Closing the Treatment Gap of Children Living with HIV
Maternal and child mortality
The use of cotrimoxazole prophylaxis in the context of HIV infection
But too many mothers and children die every year, Yes, more than half a million women die from pregnancy-related causes (that is 1 woman dying every minute).
Relative Risk of Death from All Causes for Children in Jumla ARI Program Source: Pandey, Daulaire et al, Lancet 1991.
WHO HIV update July 2018 Global epidemic Global progress and cascade
The role of CD4 in patient monitoring Amsterdam July 2018
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Jepkoech Kottutt1, Emilia D. Rivadeneira2, Susan Hrapcak2
Cepheid Symposium, IAS 23rd July 2018
AUDIT of maternal deaths using longitudinal data – case of rufiji hdss
Rashida Ferrand Getting to the first 95 for children and adolescents: Innovative approaches for pediatric case finding IAS.
Management and Development for Health (MDH)
Map 2.1 Child marriage is still common in many regions of the world, Page 20 Despite positive trends toward decreasing rates of child marriage, the practice.
Andreas D. Haas, PhD Postdoctoral fellow, ICAP at Columbia University
Start Free, Stay Free, AIDS Free
ANTENATAL, INTRAPARTUM & POSTNATAL CARE
Presentation transcript:

Pregnancy and living with HIV Coceka Nandipha Mnyani South Africa

Conflict of Interest No conflicts of interest to declare.

Successes in PMTCT 2009-2015: new paediatric HIV infections reduced by 60% in the 21 priority countries (SSA) >80% decrease – Uganda (86%), South Africa (84%), Burundi (84%) ‘…one of the great public health achievements of recent times’ UNAIDS 2016

The Soweto success story

….but, it is more than just about PMTCT

Maternal health pregnancy and HIV disease progression mortality Obstetric complications …….addressing the known and unknown

Study done in SA, 2004 – 2011 7 534 ART-naïve women; median follow-up 14 months 21 deaths (2.3%) in 918 women who became pregnant vs. 614 deaths (9.3%) in 6 616 women who did not

At time of pregnancy, median time on ART was 14 months (IQR: 7; 26); majority virally suppressed, CD4 >200 Conclusion: incident pregnancy not associated with increased risk of disease progression or death in women on ART associated with a decreased risk of LTFU …….‘healthy pregnant women effect’

To explore effects of incident pregnancy (after ART initiation) on virologic, immunologic, and clinical response to ART 3 prospective studies of HIV discordant couples From 7 African countries; 2004 to 2012

110/1041 women pregnant after ART initiation Pregnancy not associated with time to: viral suppression virologic failure WHO clinical stage III or IV disease Associated with mean decrease in CD4 count of 47 – physiological haemodilution

…third leading cause of death among women aged 15-29 globally

Maternal mortality in the era of ART Survival benefit of ART – even without advanced immune suppression (Marazzi MC et al. AIDS 2011; 25:1611–1618) Suggestion of a decline in maternal mortality with Option B+ (CD4 >350) (Auld AF et al. JAIDS 2016; 73:e11–e22) 50% decline in odds of (maternal) death from TB with expansion of ART programme (Black V et al. PLoS ONE 2016; 11)

Why maternal deaths still in women living with HIV? Maternal deaths at CHBAH, SA – 1997-2015 (n=692) 335 HIV+ – 83.8% (281) diagnosed during pregnancy Median CD4 count 136 Non-pregnancy related infections the leading cause of maternal deaths, but proportion decreasing

Why maternal deaths still in women living with HIV? 521/692 still pregnant on admission 524/692 of deaths occurred postpartum In most cases, conditions that led to the deaths occurred antenatally and intrapartum Unknown HIV status likely to: not have accessed antenatal care; die within the first 24 hours of admission; at an early gestational age

Obstetric complications and maternal deaths Puerperal sepsis, complications of hypertensive disorders, obstetric haemorrhage ?increased risk in women living with HIV …only consensus with puerperal sepsis – highest risk consistently shown to be with non-elective CS …even with widespread availability of ART (Kourtis AP et al. AIDS 2014; 28:2609–2618; Livingston EG et al. JAIDS 2016;73:74–82)

Obstetric complications Hypertensive disorders in pregnancy – pathophysiology complex Thought to have an immunologic basis Modifying effect of ART …vs. inflammatory changes associated with HIV Data inconsistent

Obstetric complications Obstetric haemorrhage – data inconsistent Definition of PPH used in studies not the same But, women with HIV more likely to receive blood and blood products (Bloch EM et al. Transfusion 2015; 55:1675–1684) >15 000 peripartum women, 51% CD4 <350, 81% on ART Pre-existing anaemia

Conclusion …it is more than just about PMTCT Need to shift focus to include maternal health; maternal mortality still a concern Reassuring data on pregnancy, HIV disease progression, and response to ART Accessing antenatal care remains critical